These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2510613)

  • 1. Body burdens of lead in hypertensive nephropathy.
    Osterloh JD; Selby JV; Bernard BP; Becker CE; Menke DJ; Tepper E; Ordonez JD; Behrens B
    Arch Environ Health; 1989; 44(5):304-10. PubMed ID: 2510613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?
    Lin JL; Lim PS
    J Hum Hypertens; 1994 Jul; 8(7):495-500. PubMed ID: 7932512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man.
    Hansen JP; Døssing M; Paulev PE
    J Occup Med; 1981 Jan; 23(1):39-43. PubMed ID: 6782204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
    Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.
    Schwartz BS; McGrail MP; Stewart W; Pluth T
    Occup Environ Med; 1994 Oct; 51(10):669-73. PubMed ID: 8000491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
    Lin JL; Ho HH; Yu CC
    Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.
    Lin JL; Lin-Tan DT; Yu CC; Li YJ; Huang YY; Li KL
    Kidney Int; 2006 Jun; 69(11):2049-56. PubMed ID: 16641918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the body burden of chelatable lead: a model and its application to lead workers.
    Araki S; Ushio K
    Br J Ind Med; 1982 May; 39(2):157-60. PubMed ID: 6802167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group.
    Staessen JA; Lauwerys RR; Buchet JP; Bulpitt CJ; Rondia D; Vanrenterghem Y; Amery A
    N Engl J Med; 1992 Jul; 327(3):151-6. PubMed ID: 1608406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level lead exposure, renal function and blood pressure.
    Staessen J
    Verh K Acad Geneeskd Belg; 1995; 57(6):527-74. PubMed ID: 8686371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilizable lead in patients with chronic renal failure.
    Koster J; Erhardt A; Stoeppler M; Mohl C; Ritz E
    Eur J Clin Invest; 1989 Apr; 19(2):228-33. PubMed ID: 2499482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated lead burden in Chinese patients without occupational lead exposure.
    Lin JL; Lim PS
    Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children.
    Thomas DJ; Chisolm J
    J Pharmacol Exp Ther; 1986 Dec; 239(3):829-35. PubMed ID: 3098962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of environmental and occupational lead exposure.
    Loghman-Adham M
    Environ Health Perspect; 1997 Sep; 105(9):928-38. PubMed ID: 9300927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
    Colleoni N; D'Amico G
    Nephron; 1986; 44(1):32-5. PubMed ID: 3092121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.